CN104027679A - Traditional Chinese medicine composition for treating cataract - Google Patents
Traditional Chinese medicine composition for treating cataract Download PDFInfo
- Publication number
- CN104027679A CN104027679A CN201410205152.5A CN201410205152A CN104027679A CN 104027679 A CN104027679 A CN 104027679A CN 201410205152 A CN201410205152 A CN 201410205152A CN 104027679 A CN104027679 A CN 104027679A
- Authority
- CN
- China
- Prior art keywords
- parts
- chinese medicine
- traditional chinese
- medicine composition
- semen
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
The invention discloses a traditional Chinese medicine composition for treating cataract. The traditional Chinese medicine composition is composed of the following raw materials in parts by weight: 15-18 parts of scutellaria baicalensis, 12-14 parts of lotus leaf, 3-5 parts of tuckahoe, 10-15 parts of wild chrysanthemum flower, 3-5 parts of rhizoma typhonii, 2-4 parts of moutan bark, 8-10 parts of agaric, 2-4 parts of lindera aggregata, 4-6 parts of semen raphani, 3-5 parts of semen coicis, 2-4 parts of astragalus membranaceus, 1-3 parts of gynostemma pentaphylla, 5-7 parts of folium mori, 4-6 parts of feather cockscomb seed, 3-5 parts of basil seed, 1-3 parts of xanthiun strumarium linn, 5-7 parts of coriander, 3-5 parts of dog tail grass, 2-4 parts of butterflybush flower, 1-3 parts of common sage herb, 2-4 parts of horsetail and 1-3 parts of Hibiscus manihot. The traditional Chinese medicine disclosed by the invention has the functions of clearing liver and improving vision, clearing away heat and toxic materials, nourishing liver and kidney and removing nebula; the traditional Chinese medicine composition disclosed by the invention is small in toxic or side effect, convenient to take, easy to absorb, quick to become effective, and good in curative effect; as shown in clinical experiments, the cure rate of the traditional Chinese medicine disclosed by the invention is 95% and the effective rate is 99%.
Description
Technical field
The present invention relates to one and treat cataractous Chinese medicine composition, belong to the field of Chinese medicines.
Background technology
Cataract is a kind of common ocular disease, a kind ofly can cause the blind disease of patient, cataractous symptom is blurred vision, keep in dark place, look more, near-sighted degree increases, see that object color is dark or be yellow, even diplopia and see the symptoms such as deformation of body, showing as carrying out property of vision goes down, sometimes under bright background, can see fixing stain, main and the nutrient metabolism of cataractous pathogenic factor, sunlight and ultraviolet, extraneous temperature, anoxia, endocrine regulation, it is relevant to there is the factors such as dehydration in human body; At present, treating cataractous most effectual way is surgical removal treatment, and operative treatment can only take stopgap measures and can not effect a permanent cure; Postcataract may cause a series of complication, and the patient who suffers from hypertension, heart disease or Other diseases is difficult for performing the operation, and is all old people mostly again owing to suffering from cataractous patient, and operation meeting brings very large psychological burden to them.
Summary of the invention
The object of the present invention is to provide one to treat cataractous Chinese medicine composition.
The present invention adopts following technical scheme:
Treat cataractous Chinese medicine composition, the weight portion of its constitutive material is: Radix Scutellariae 15-18, Folium Nelumbinis 12-14, Rhizoma Smilacis Glabrae 3-5, Flos Chrysanthemi Indici 10-15, Rhizoma Typhonii 3-5, Cortex Moutan 2-4, Auricularia 8-10, Radix Linderae 2-4, Semen Raphani 4-6, Semen Coicis 3-5, Radix Astragali 2-4, Herb Gynostemmae Pentaphylli 1-3, Folium Mori 5-7, Semen Celosiae 4-6, FRUCTUS OCIMI 3-5, spend louse female 1-3, tomentosecalyx elsholtzia leaf 5-7, herba setariae viridis grass 3-5, Flos Buddlejae 2-4, Herba Salviae Plebeiae 1-3, Herba Equiseti Hiemalis 2-4 and vegetable Furong 1-3 in vain.
Treat cataractous Chinese medicine composition, the weight portion of its constitutive material is: Radix Scutellariae 16, Folium Nelumbinis 13, Rhizoma Smilacis Glabrae 4, Flos Chrysanthemi Indici 12, Rhizoma Typhonii 4, Cortex Moutan 3, Auricularia 9, the Radix Linderae 3, Semen Raphani 5, Semen Coicis 4, the Radix Astragali 3, Herb Gynostemmae Pentaphylli 2, Folium Mori 6, Semen Celosiae 5, FRUCTUS OCIMI 4, spend louse female 2, tomentosecalyx elsholtzia leaf 6, herba setariae viridis grass 4, Flos Buddlejae 3, Herba Salviae Plebeiae 2, Herba Equiseti Hiemalis 3 and vegetable Furong 2 in vain.
FRUCTUS OCIMI is the mature fruit of labiate Herba Ocimi (Herba Ocimi Pilosi); Herba Salviae Plebeiae is the aerial parts of labiate Herba Salviae Plebeiae; Vegetable Furong is annual herb Malvaceae Abelmoschus plant.
Consumption and usage: take Chinese medicine composition of the present invention, every day, potion, 20 days was a course for the treatment of, cure general 3-4 the course for the treatment of.
Beneficial effect of the present invention:
Chinese medicine of the present invention has effect of liver heat removing and eyesight improving, heat-clearing and toxic substances removing, nourishing the liver nourishing kidney and improving acuity of vision and removing nebula; That the present invention has no side effect is little, taking convenience, be easy to absorption, instant effect, good effect, proves that Chinese medicine cure rate of the present invention is up to 95%, effective percentage 99% through clinical trial.
Detailed description of the invention
Embodiment 1: treat cataractous Chinese medicine composition, the weight portion (g) of its constitutive material is: Radix Scutellariae 16, Folium Nelumbinis 13, Rhizoma Smilacis Glabrae 4, Flos Chrysanthemi Indici 12, Rhizoma Typhonii 4, Cortex Moutan 3, Auricularia 9, the Radix Linderae 3, Semen Raphani 5, Semen Coicis 4, the Radix Astragali 3, Herb Gynostemmae Pentaphylli 2, Folium Mori 6, Semen Celosiae 5, FRUCTUS OCIMI 4, spend louse female 2, tomentosecalyx elsholtzia leaf 6, herba setariae viridis grass 4, Flos Buddlejae 3, Herba Salviae Plebeiae 2, Herba Equiseti Hiemalis 3 and vegetable Furong 2 in vain.
Consumption and usage: take Chinese medicine composition of the present invention, every day, potion, 20 days was a course for the treatment of, cure general 3-4 the course for the treatment of.
Model case:
Case 1: willow, female, 73 years old, suffer from cataract more than ten years, eyes are fuzzy, almost cannot see thing night, deeply pull the devil by the tail, take the cataractous medicine of multiple treatment, its effect is undesirable, after take Chinese medicine composition of the present invention, every day, potion, took after two courses for the treatment of, and vision increases, continue to take after two courses for the treatment of, vision restoration is normal.
Case 2: Hu, man, 47 years old, suffer from cataract 2 years, what vision was gradual goes down, increase the weight of in the recent period, take Chinese medicine composition of the present invention, every day, potion, serve on after one month, vision is obviously improved, and continues to take after two courses for the treatment of, and vision restoration is normal, so far not recurrence.
Case 3: ancient certain, female, 68 years old, suffers from cataract more than ten years, vision only has 0.4,0.3, blurred vision, western medicine is repeatedly invalid, after take Chinese medicine composition of the present invention, every day, potion, serve on after three courses for the treatment of, reverted to 0.7,0.8 through looking into two eye visions, so far not in recurrence.
Claims (2)
1. the cataractous Chinese medicine composition for the treatment of, is characterized in that the weight portion of its constitutive material is: Radix Scutellariae 15-18, Folium Nelumbinis 12-14, Rhizoma Smilacis Glabrae 3-5, Flos Chrysanthemi Indici 10-15, Rhizoma Typhonii 3-5, Cortex Moutan 2-4, Auricularia 8-10, Radix Linderae 2-4, Semen Raphani 4-6, Semen Coicis 3-5, Radix Astragali 2-4, Herb Gynostemmae Pentaphylli 1-3, Folium Mori 5-7, Semen Celosiae 4-6, FRUCTUS OCIMI 3-5, spend louse female 1-3, tomentosecalyx elsholtzia leaf 5-7, herba setariae viridis grass 3-5, Flos Buddlejae 2-4, Herba Salviae Plebeiae 1-3, Herba Equiseti Hiemalis 2-4 and vegetable Furong 1-3 in vain.
2. the cataractous Chinese medicine composition for the treatment of according to claim 1, is characterized in that the weight portion of its constitutive material is: Radix Scutellariae 16, Folium Nelumbinis 13, Rhizoma Smilacis Glabrae 4, Flos Chrysanthemi Indici 12, Rhizoma Typhonii 4, Cortex Moutan 3, Auricularia 9, the Radix Linderae 3, Semen Raphani 5, Semen Coicis 4, the Radix Astragali 3, Herb Gynostemmae Pentaphylli 2, Folium Mori 6, Semen Celosiae 5, FRUCTUS OCIMI 4, spend louse female 2, tomentosecalyx elsholtzia leaf 6, herba setariae viridis grass 4, Flos Buddlejae 3, Herba Salviae Plebeiae 2, Herba Equiseti Hiemalis 3 and vegetable Furong 2 in vain.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201410205152.5A CN104027679A (en) | 2014-05-15 | 2014-05-15 | Traditional Chinese medicine composition for treating cataract |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201410205152.5A CN104027679A (en) | 2014-05-15 | 2014-05-15 | Traditional Chinese medicine composition for treating cataract |
Publications (1)
Publication Number | Publication Date |
---|---|
CN104027679A true CN104027679A (en) | 2014-09-10 |
Family
ID=51458823
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201410205152.5A Pending CN104027679A (en) | 2014-05-15 | 2014-05-15 | Traditional Chinese medicine composition for treating cataract |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN104027679A (en) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN104689110A (en) * | 2015-03-03 | 2015-06-10 | 李军 | Medicament for treating radiation cataract |
Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102106977A (en) * | 2009-12-24 | 2011-06-29 | 孟繁英 | Externally-applied sturdy vision eyeshield liquid medicine for preventing and treating oculopathy |
-
2014
- 2014-05-15 CN CN201410205152.5A patent/CN104027679A/en active Pending
Patent Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102106977A (en) * | 2009-12-24 | 2011-06-29 | 孟繁英 | Externally-applied sturdy vision eyeshield liquid medicine for preventing and treating oculopathy |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN104689110A (en) * | 2015-03-03 | 2015-06-10 | 李军 | Medicament for treating radiation cataract |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN102277248A (en) | Nourishing wine | |
CN1765416A (en) | Health caring plaster | |
CN103655979A (en) | Traditional Chinese medicine composition for treating conjunctivitis | |
CN101559195A (en) | Epilepsy therapy capsule and preparation method thereof | |
CN104068158B (en) | Sea cucumber health-strengthening tea and preparation method thereof | |
CN102813876B (en) | Traditional Chinese medicine for treating postpartum lochiorrhea by activating blood and removing blood stasis | |
CN103468505A (en) | Yellow wine with health-care effect on patients with diabetes | |
CN104027679A (en) | Traditional Chinese medicine composition for treating cataract | |
CN103272132A (en) | Preparation method of fermented medicine for treating animal skin disease | |
CN103751500A (en) | Chinese herbal medicine granule for treating cataract and preparation method thereof | |
CN103768244A (en) | Drug for treating cataract | |
CN102784301A (en) | Traditional Chinese medicine treating early cataract and its preparation method | |
CN103316283B (en) | Traditional Chinese medicinal composition for treating chronic cholecystitis, and preparation method thereof | |
CN105920130A (en) | Preparation method and externally used ointment of traditional Chinese medicine for treating talalgia | |
CN104826014A (en) | Traditional Chinese medicine preparation for treating type-II diabetes and preparation method thereof | |
CN104258311A (en) | Traditional Chinese medicine decoction for treating uremia | |
CN105267898A (en) | Preparation method of traditional Chinese medicinal honeyed pill for preventing kidney deficiency | |
CN103990083A (en) | Traditional Chinese medicine composition for treating postpartum lochiorrhea | |
CN103505584A (en) | Traditional Chinese medicine used for treating glaucoma | |
CN103550420A (en) | Traditional Chinese medicine for treating urticaria | |
CN103638418A (en) | Traditional Chinese medicine liquid for treating amnesia and preparation method thereof | |
CN106215104A (en) | A kind of Chinese medicine composition treating menoxenia, amenorrhea | |
CN104825762A (en) | Traditional Chinese medicine with function of eyesight improvement | |
CN106344769A (en) | Chinese medicinal decoction for treating nyctalopia | |
CN104288440A (en) | Traditional Chinese medicine ointment for treating vitiligo |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
RJ01 | Rejection of invention patent application after publication |
Application publication date: 20140910 |
|
RJ01 | Rejection of invention patent application after publication |